The U.S. Food and Drug Administration is in the process of issuing a draft enforcement policy on cannabis-derived compounds, including cannabidiol (CBD). That draft is currently at the White House for review.

The U.S. Food and Drug Administration is in the process of issuing a draft enforcement policy on cannabis-derived compounds, including cannabidiol (CBD). That draft is currently at the White House for review. Pet product companies that formulate with CBD, or are considering it, should mind the outcome of that policy, Emily Lyons, lawyer with Husch Blackwell, said during her presentation at Petfood Forum CONNECT. Read more.

_________________

Wall, Tim. “CBD Pet Products May Face More FDA Warnings, Lawsuits.” Petfoodindustry.com, Petfoodindustry.com, 29 Sept. 2020, https://www.petfoodindustry.com/articles/9602-cbd-pet-products-may-face-more-fda-warnings-lawsuits